Pharmacological characterization of cellular mechanisms of the renal vasodilatory effect of nicotine in rats

European Journal of Pharmacology

Volumn 588, Issue 2-3, 2008, Pages 294-300

  El Mas, Mahmoud M ^a   El gowilly, Sahar M ^a   Gohar, Eman Y ^a   Ghazal, Abdel Rheem M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Endothelium; K+ channels; Nicotine; Nitrergic neurotransmission; Nitric oxide synthase; Perfused kidney; Vasodilation

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOPYRIDINE; ARGININE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DICLOFENAC; GLIBENCLAMIDE; GUANETHIDINE; GUANYLATE CYCLASE; HEXAMETHONIUM; INWARDLY RECTIFYING POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MUSCARINIC RECEPTOR BLOCKING AGENT; NEOSTIGMINE; NICOTINE; NITRIC OXIDE SYNTHASE; NORADRENALIN; POTASSIUM CHANNEL; PROPRANOLOL; TETRYLAMMONIUM; VOLTAGE GATED POTASSIUM CHANNEL;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CHOLINERGIC ACTIVITY; CONCENTRATION RESPONSE; IN VITRO STUDY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CHOLIC ACIDS; KIDNEY; MALE; NICOTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERFUSION; POTASSIUM CHANNELS; PROSTAGLANDINS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; VASODILATION;

EID: 44649152219     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.048     Document Type: Article

References (45)

1. Adler M., Albuquerque E.X., and Lebeda F.J. Kinetic analysis of end plate currents altered by atropine and scopolamine. Mol. Pharmacol. 14 (1978) 514-529
2. Ay I., and Tuncer M. Vasodilatation induced by nicotine in the isolated perfused rat kidney. Gen. Pharmacol. 30 (1998) 651-654
3. Ayajiki K., Fujioka H., Torii R., Toda N., and Okamura T. Endothelial and neuronal functions in cerebral and temporal arteries from monkeys fed a high-cholesterol diet. J. Cardiovasc. Pharmacol. 40 (2002) 456-466
4. Black C.E., Huang N., Neligan P.C., Levine R.H., Lipa J.E., Lintlop S., Forrest C.R., and Pang C.Y. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R1097-R1104
5. Brier M.E., and Harding G.B. Pharmacokinetics and pharmacodynamics of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 249 (1989) 372-377
6. Bultmann R., von Kugelgen I., and Starke K. Adrenergic and purinergic cotransmission in nicotine-evoked vasoconstriction in rabbit ileocolic arteries. Naunyn Schmiedebergs Arch. Pharmacol. 344 (1991) 174-182
7. Connor E.A., Levy S.M., and Parsons R.L. Kinetic analysis of atropine-induced alterations in bullfrog ganglionic fast synaptic currents. J. Physiol. 337 (1983) 137-158
8. Dohi Y., Kojima M., and Sato K. Endothelial modulation of contractile responses in arteries from hypertensive rats. Hypertension 28 (1996) 732-737
9. Donald J.A., Broughton B.R., and Bennett M.B. Vasodilator mechanisms in the dorsal aorta of the giant shovelnose ray, Rhinobatus typus (Rajiformes; Rhinobatidae). Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 137 (2004) 21-31
10. Eguchi S., Miyashita S., Kitamura Y., and Kawasaki H. α3β4-Nicotinic receptors mediate adrenergic nerve- and peptidergic (CGRP) nerve-dependent vasodilation induced by nicotine in rat mesenteric arteries. Br. J. Pharmacol. 151 (2007) 1216-1223
11. I-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 288 (1999) 455-462
12. 1-adrenoceptor reactivity in rat aortic smooth muscle. Eur. J. Pharmacol. 322 (1997) 201-210
13. El-Mas M.M., Afify E.A., Omar A.G., Mohy El-Din M.M., and Sharabi F.M. Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations. Eur. J. Pharmacol. 468 (2003) 217-224
14. 1-dopaminergic receptor mediates cyclosporine-SKF38393 renovascular interaction. Can. J. Physiol. Pharmacol. 83 (2005) 1129-1136
15. El-Mas M.M., Mohy El-Din M.M., El-gowilly S.M., and Sharabi F.M. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and β-adrenergic renal vasodilations. Eur. J. Pharmacol. 487 (2004) 149-158
16. El-Mas M.M., Mohy El-Din M.M., El-gowilly S.M., and Sharabi F.M. Regional and endothelial differences in the cyclosporine attenuation of adenosine receptor-mediated vasorelaxations. J. Cardiovasc. Pharmacol. 43 (2004) 562-573
17. Feitelson J.B., Rowell P.P., Roberts C.S., and Fleming J.T. Two week nicotine treatment selectively increases bone vascular constriction in response to norepinephrine. J. Orthop. Res. 21 (2003) 497-502
18. Feletou M., and Vanhoutte P.M. Endothelium-derived hyperpolarizing factor. Clin. Exp. Pharmacol. Physiol. 23 (1996) 1082-1090
19. Gerkens J.F. Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators. J. Pharmacol. Exp. Ther. 250 (1989) 1105-1112
20. González A.A., Farré R., and Clavé P. Different responsiveness of excitatory and inhibitory enteric motor neurons in the human esophagus to electrical field stimulation and to nicotine. Am. J. Physiol. Gastrointest. Liver. Physiol. 287 (2004) G299-G306
21. Groudine S.B., and Morley J.N. Recent problems with paracervical vasopressin: a possible synergistic reaction with nicotine. Med. Hypotheses 47 (1996) 19-21
22. Haak T., Jungmann E., Raab C., and Usadel K.H. Elevated endothelin-1 levels after cigarette smoking. Metabolism 43 (1994) 267-269
23. Halimi J.M., and Mimran A. Renal effects of smoking: potential mechanisms and perspectives. Nephrol. Dial. Transplant. 15 (2000) 938-940
24. Höcherl K., Kammerl M., Kees F., Krämer B.K., Grobecker H.F., and Kurtz A. Role of renal nerves in stimulation of renin, COX-2, and nNOS in rat renal cortex during salt deficiency. Am. J. Physiol. Renal. Physiol. 282 (2002) F478-F484
25. Huang Y., Chan F.L., Lau C.W., Tsang S.Y., He G.W., Chen Z.Y., and Yao X. Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels. Br. J. Pharmacol. 135 (2002) 1467-1476
26. 2-adrenoceptors mediate nicotine-induced NOergic neurogenic dilation in porcine basilar arteries. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H808-H816
27. Lindauer U., Vogt J., Schuh-Hofer S., Dreier J.P., and Dirnagl U. Cerebrovascular Vasodilation to Extraluminal Acidosis Occurs via Combined Activation of ATP-Sensitive and Ca2+-Activated Potassium Channels. J. Cereb. Blood Flow Metab. 23 (2003) 1227-1238
28. Marano G., Ramirez A., Mori I., and Ferrari A.U. Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats. Cardiovasc. Res. 42 (1999) 201-205
29. Mayhan W.G. Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch. J. Lab. Clin. Med. 133 (1999) 48-54
30. Mohy El-Din M.M., and Malik K.U. Differential effect of w-conotoxin on release of the adrenergic transmitter and the vasoconstrictor response to noradrenaline in the rat isolated kidney. Br. J. Pharmacol. 94 (1988) 355-362
31. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
32. Moshage H., Kok B., Huizenga J.R., and Jansen P.L. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 41 (1995) 892-896
33. 7-nAChR-mediated cerebral nitrergic neurogenic vasodilation. J. Cereb. Blood Flow 26 (2006) 1562-1576
34. Palmer R.M.J., Ashton D.S., and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond.) 333 (1988) 664-666
35. Rand M.J., and Li C.G. Activation of noradrenergic and nitrergic mechanisms in the rat anococcygeus muscle by nicotine. Clin. Exp. Pharmac. Physiol. 19 (1992) 103-111
36. Shiraki H., Kawasaki H., Tezuka S., Nakatsuma A., and Kurosaki Y. Endogenous calcitonin gene-related peptide (CGRP) mediates adrenergic-dependent vasodilation induced by nicotine in mesenteric resistance arteries of the rat. Br. J. Pharmacol. 130 (2000) 1083-1091
37. Si M.L., and Lee T.J. Alpha7-nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation. Circ. Res. 91 (2002) 62-69
38. Stephan D., Billing A., Krieger J.-P., Grima M., Fabre M., Hofner M., Imbs J.-L., and Barthelmebs M. Endothelium-dependent relaxation in the isolated rat kidney: impairment by cyclosporine A. J. Cardiovasc. Pharmacol. 26 (1995) 859-868
39. Tang G., Hanna S.T., and Wang R. Effects of nicotine on K+ channel currents in vascular smooth muscle cells from rat tail arteries. Eur. J. Pharmacol. 364 (1999) 247-254
40. Thompson J., and Khalil R.A. Gender differences in the regulation of vascular tone. Clin. Exp. Pharmacol. Physiol. 30 (2003) 1-15
41. Vargas F., Sabio J.M., and Luna J.D.D. Contribution of endothelium derived relaxing factors to acetylcholine induced vasodilatation in the rat kidney. Cardiovasc. Res. 28 (1994) 1373-1377
42. Wang R., and Wang Z. Three different vasoactive responses of rat tail artery to nicotine. Can. J. Physiol. Pharmacol. 78 (2000) 20-28
43. Wang X., and Loutzenhiser R. Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF. Am. J. Physiol. Renal. Physiol. 282 (2002) F124-F132
44. Wang X., Trottier G., and Loutzenhiser R. Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF. Am. J. Physiol. Renal. Physiol. 285 (2003) F540-F549
45. Zhang W., Edvinsson L., and Lee T.J. Mechanism of nicotine-induced relaxation in the porcine basilar artery. J. Pharmacol. Exp. Ther. 284 (1998) 790-797